(315 days)
Not Found
No
The summary describes a biological mesh for tissue reinforcement and does not mention any computational or analytical functions that would typically involve AI/ML.
No.
The device is a surgical mesh used to reinforce soft tissues, not to treat a disease or condition in itself.
No
The device description clearly states ProPatch is a "surgical mesh manufactured from bovine pericardium" used for "reinforcing soft tissues where weakness exists," indicating it is a therapeutic implant for repair, not a diagnostic tool.
No
The device description clearly states that ProPatch is a surgical mesh manufactured from bovine pericardium, which is a physical material, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use of ProPatch is for surgical implantation to reinforce soft tissues. This is a therapeutic and structural function within the body.
- Device Description: The device is a surgical mesh made from bovine pericardium, designed to be implanted.
- Lack of Diagnostic Function: There is no mention of this device being used to examine specimens from the human body to provide information for diagnosis, monitoring, or compatibility. IVDs are used outside the body to analyze samples like blood, urine, or tissue.
The information provided clearly describes a surgically implanted medical device, not an in vitro diagnostic product.
N/A
Intended Use / Indications for Use
ProPatch® is indicated for implantation to reinforce soft tissues where weakness exists including, but not limited to: defects of the abdominal and thoracic wall, muscle flap reinforcement, hernias, suture-line reinforcement, and reconstructive procedures.
ProPatch® is indicated for the reinforcement, where weakness exists, of soft tissues repaired by sutures or by suture anchors during tendon repair surgery including, but not limited to: reinforcement of rotator cuff, patellar, Achilles, biceps, quadricens, or other tendons.
Product codes
FTM
Device Description
ProPatch Soft Tissue Repair Matrix (ProPatch) is a surgical mesh manufactured from bovine pericardium. Decellularized tissues undergo chemical microbial reduction and viral inactivation processes, are inspected for freedom from defects, packaged, and terminally sterilized via gamma radiation. ProPatch is comprised of a single tissue layer, nominally 0.6 mm thick, and is provided as a sterile and non-pyrogenic product that is fully hydrated and ready for use without the need for rinsing or rehydration prior to implantation.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
abdominal and thoracic wall, muscle flap, hernias, rotator cuff, patellar, Achilles, biceps, quadricens, or other tendons.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The equivalence of the biomechanical properties of the proposed device to the predicate device has been demonstrated through testing the characteristics identified below:
- Tensile Properties the manner in which a material reacts to forces applied in tension.
- Tear Propagation Resistance - the ability of a material to resist tearing.
- Bursting Strength the ability of a material to resist bursting due to pressure exerted on the material.
- Suture Retention Strength - the ability of a material to resist tearing from tension applied to suture that has been passed through the material.
The characteristics outlined above were tested and the biomechanical properties of the proposed device were found to be substantially equivalent to the biomechanical properties of the predicate device.
The decellularization efficiency of the improved process was demonstrated by evaluating the cellular content of finished devices. The decellularization observed was equivalent to that observed in the predicate device. Therefore, the decellularization efficiency of the improved process is equivalent to the process by which the predicate device is manufactured.
In summary, all testing demonstrates that the proposed device has the same technical characteristics as the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.
0
K110581
p. 1 of 2
i ----
ProPatch® Soft Tissue Repair Matrix CryoLife, Inc.
JAN 1 0 2012
510(k) Summary
| Submitter: | CryoLife, Inc. |
|---|---|
| Contact: | Kimberly DiCono |
| Senior Regulatory Affairs Specialist | |
| Address: | 1655 Roberts Blvd. NW |
| Kennesaw, GA 30144 | |
| Phone: | 770-419-3355 |
| Fax: | 770-590-3783 |
| Date: | December 21, 2011 |
| Trade Name: | ProPatch® Soft Tissue Repair Matrix |
| Common Name: | Surgical Mesh |
| Classification Name: | Mesh, Surgical (21 CFR 878.3300, Product Code FTM) |
| Predicate Device: | ProPatch® Soft Tissue Repair Matrix |
| K101587 - September 16, 2010 |
Product Code FTM CryoLife, Inc.
1655 Roberts Blvd. NW Kennesaw, GA 30144
Intended Use:
ProPatch® is indicated for implantation to reinforce soft tissues where weakness exists including, but not limited to: defects of the abdominal and thoracic wall, muscle flap reinforcement, hernias, suture-line reinforcement, and reconstructive procedures.
ProPatch® is indicated for the reinforcement, where weakness exists, of soft tissues repaired by sutures or by suture anchors during tendon repair surgery including, but not limited to: reinforcement of rotator cuff, patellar, Achilles, biceps, quadricens, or other tendons.
Device Description:
ProPatch Soft Tissue Repair Matrix (ProPatch) is a surgical mesh manufactured from bovine pericardium. Decellularized tissues undergo chemical microbial reduction and viral inactivation processes, are inspected for freedom from defects, packaged, and terminally sterilized via gamma radiation.
CONFIDENTIAL
1
ProPatch® Soft Tissue Repair Matrix CryoLife, Inc.
ProPatch is comprised of a single tissue layer, nominally 0.6 mm thick, and is provided as a sterile and non-pyrogenic product that is fully hydrated and ready for use without the need for rinsing or rehydration prior to implantation.
Equivalence to Predicate Device:
The improved manufacturing process is very similar to the process by which the predicate device is manufactured. However, the improved process utilizes raw material (bovine pericandia) that are packed and shipped to the device manufacturer in a different manner. Additionally, process changes have been made to remove the use of antimicrobials, thereby eliminating concerns of patient sensitivity to potential residuals of these antimicrobials. Despite these minor changes to the process, the technical characteristics of the device are the same.
The equivalence of the biomechanical properties of the proposed device to the predicate device has been demonstrated through testing the characteristics identified below:
- Tensile Properties the manner in which a material reacts to forces applied in tension.
- l Tear Propagation Resistance - the ability of a material to resist tearing.
- Bursting Strength the ability of a material to resist bursting due to pressure ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------exerted on the material.
- । Suture Retention Strength - the ability of a material to resist tearing from tension applied to suture that has been passed through the material.
The characteristics outlined above were tested and the biomechanical properties of the proposed device were found to be substantially equivalent to the biomechanical properties of the predicate device.
The decellularization efficiency of the improved process was demonstrated by evaluating the cellular content of finished devices. The decellularization observed was equivalent to that observed in the predicate device. Therefore, the decellularization efficiency of the improved process is equivalent to the process by which the predicate device is manufactured.
In summary, all testing demonstrates that the proposed device has the same technical characteristics as the predicate device.
CONFIDENTIAL
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
CryoLife, Incorporated % Ms. Kimberly DiCono Senior Regulatory Affairs Specialist 1655 Roberts Boulevard, Northwest Kennesaw, Georgia 30144
JAN 1 0 2012
Re: K110581
Trade/Device Name: ProtPatch® Soft Tissue Repair Matrix Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: Class II Product Code: FTM Dated: December 21, 2011 Received: December 23, 2011
Dear Ms. DiCono:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
3
Page 2 - Ms. Kimberly DiCono
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours
For
Donlin.
Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
ProPatch® Soft Tissue Repair Matrix CryoLife, Inc.
Indications for Use
510(k) Number (if known): K110581
ProPatch® Soft Tissue Repair Matrix Device Name:
Indications for Use:
Non-Joint Related Repair
ProPatch is indicated for implantation to reinforce soft tissues where weakness exists, including, but not limited to: defects of the abdominal and thoracic wall, muscle flap reinforcement, hernias, suture-line reinforcement, and reconstructive procedures.
Joint Related Repair
ProPatch is indicated for reinforcement where weakness exists, of soft tissues repaired by sutures or by suture anchors during tendon repair surgery including, but not limited to: reinforcement of rotator cuff, patellar, Achilles, biceps, quadriceps, or other tendons.
Prescription Use
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Da. DKime for MXM
(Division Sign-Off)
CONFIDENTIAL
Division of Surgical, Orthopedic, and Restorative Devices
Page 1 of 1
510(k) Number K110581